106 related articles for article (PubMed ID: 24003488)
1. [Evaluation of pharmacokinetic interaction of aphobazole with CYP1A2 drug-substrate in experiments].
Novitskaia IaG; Litvin AA; Viglinskaia AO; Zherdev VP
Eksp Klin Farmakol; 2013; 76(6):30-3. PubMed ID: 24003488
[TBL] [Abstract][Full Text] [Related]
2. [In vivo evaluation of the metabolic ratio of CYP2C9 and CYP1A2 drug markers after administration of afobazole in comparison to standard inducers and inhibitors of cytochromes].
Novitskaia IaG; Gribakina OG; Kolyvanov GB; Zherdev VP; Smirnov VV; Seredenin SB
Eksp Klin Farmakol; 2013; 76(11):36-9. PubMed ID: 24555232
[TBL] [Abstract][Full Text] [Related]
3. [Pharmacokinetics of afobazole metabolite (M-11) in rats].
Bastrygin DV; Viglinskaia AO; Kolyvanov GB; Litvin AA; Bochkov PO; Mozhaeva TIa; Zherdev VP
Eksp Klin Farmakol; 2011; 74(7):22-6. PubMed ID: 21894764
[TBL] [Abstract][Full Text] [Related]
4. Effects of rutaecarpine on the metabolism and urinary excretion of caffeine in rats.
Noh K; Seo YM; Lee SK; Bista SR; Kang MJ; Jahng Y; Kim E; Kang W; Jeong TC
Arch Pharm Res; 2011 Jan; 34(1):119-25. PubMed ID: 21468923
[TBL] [Abstract][Full Text] [Related]
5. Accumulation of theophylline, theobromine and paraxanthine in the fetal rat brain following a single oral dose of caffeine.
Wilkinson JM; Pollard I
Brain Res Dev Brain Res; 1993 Oct; 75(2):193-9. PubMed ID: 8261611
[TBL] [Abstract][Full Text] [Related]
6. [EVALUATION OF THE PHARMACOKINETIC INTERACTION OF AFOBAZOLE WITH CYP2C9 ENZYME DRUG SUBSTRATE OF CYTOCHROME P450].
Gribakina OG; Kolyvanov GB; Litvin AA; Smirnov VV; Shevchenko RV; Zherdev VP
Eksp Klin Farmakol; 2015; 78(12):18-22. PubMed ID: 27051923
[TBL] [Abstract][Full Text] [Related]
7. Biotransformation of caffeine, paraxanthine, theobromine and theophylline by cDNA-expressed human CYP1A2 and CYP2E1.
Gu L; Gonzalez FJ; Kalow W; Tang BK
Pharmacogenetics; 1992 Apr; 2(2):73-7. PubMed ID: 1302044
[TBL] [Abstract][Full Text] [Related]
8. Effects of the aqueous extract from Salvia miltiorrhiza Bunge on caffeine pharmacokinetics and liver microsomal CYP1A2 activity in humans and rats.
Wang X; Yeung JH
J Pharm Pharmacol; 2010 Aug; 62(8):1077-83. PubMed ID: 20663043
[TBL] [Abstract][Full Text] [Related]
9. Effect of toluidines and dinitrotoluenes on caffeine metabolic ratio in rat.
Jodynis-Liebert J; Matuszewska A
Toxicol Lett; 1999 Jan; 104(1-2):159-65. PubMed ID: 10048762
[TBL] [Abstract][Full Text] [Related]
10. Comparative pharmacokinetics of caffeine and three metabolites in clinically normal horses and donkeys.
Peck K; Mealey KL; Matthews NS; Taylor TS
Am J Vet Res; 1997 Aug; 58(8):881-4. PubMed ID: 9256975
[TBL] [Abstract][Full Text] [Related]
11. Excretion of afobazole and its metabolites with urine and feces in rats.
Viglinskaya AO; Kolyvanov GB; Litvin AA; Zherdev VP; Seredenin SB
Bull Exp Biol Med; 2008 Apr; 145(4):440-2. PubMed ID: 19110588
[TBL] [Abstract][Full Text] [Related]
12. [Pharmacokinetics of afobazole in rats].
Seredenin SB; Viglinskaia AO; Kolyvanov GB; Litvin AA; Kravtsova OIu; Zherdev VP
Eksp Klin Farmakol; 2007; 70(2):59-64. PubMed ID: 17523455
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of caffeine and its demethylated metabolites in lactating adult rabbits and neonatal offspring. Predictions of breast milk to serum concentration ratios.
McNamara PJ; Burgio D; Yoo SD
Drug Metab Dispos; 1992; 20(2):302-8. PubMed ID: 1352225
[TBL] [Abstract][Full Text] [Related]
14. High-performance liquid chromatographic separation of caffeine, theophylline, theobromine and paraxanthine in rat brain and serum.
Parra P; Limon A; Ferre S; Guix T; Jane F
J Chromatogr; 1991 Sep; 570(1):185-90. PubMed ID: 1797825
[TBL] [Abstract][Full Text] [Related]
15. Pregnancy-induced changes in the pharmacokinetics of caffeine and its metabolites.
Yu T; Campbell SC; Stockmann C; Tak C; Schoen K; Clark EA; Varner MW; Spigarelli MG; Sherwin CM
J Clin Pharmacol; 2016 May; 56(5):590-6. PubMed ID: 26358647
[TBL] [Abstract][Full Text] [Related]
16. Combined phenotypic assessment of CYP1A2, CYP2C19, CYP2D6, CYP3A, N-acetyltransferase-2, and xanthine oxidase with the "Cooperstown cocktail".
Streetman DS; Bleakley JF; Kim JS; Nafziger AN; Leeder JS; Gaedigk A; Gotschall R; Kearns GL; Bertino JS
Clin Pharmacol Ther; 2000 Oct; 68(4):375-83. PubMed ID: 11061577
[TBL] [Abstract][Full Text] [Related]
17. Paraxanthine/Caffeine Concentration Ratios in Hair: An Alternative for Plasma-Based Phenotyping of Cytochrome P450 1A2?
De Kesel PM; Lambert WE; Stove CP
Clin Pharmacokinet; 2015 Jul; 54(7):771-81. PubMed ID: 25603821
[TBL] [Abstract][Full Text] [Related]
18. Serum metabolite/caffeine ratios as a test for liver function.
Jodynis-Liebert J; Flieger J; Matuszewska A; Juszczyk J
J Clin Pharmacol; 2004 Apr; 44(4):338-47. PubMed ID: 15051740
[TBL] [Abstract][Full Text] [Related]
19. A fluvoxamine-caffeine interaction study.
Jeppesen U; Loft S; Poulsen HE; Brśen K
Pharmacogenetics; 1996 Jun; 6(3):213-22. PubMed ID: 8807660
[TBL] [Abstract][Full Text] [Related]
20. Comparative pharmacokinetics of caffeine and its primary demethylated metabolites paraxanthine, theobromine and theophylline in man.
Lelo A; Birkett DJ; Robson RA; Miners JO
Br J Clin Pharmacol; 1986 Aug; 22(2):177-82. PubMed ID: 3756065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
